Seres Therapeutics(MCRB) - 2022 Q3 - Earnings Call Transcript
Seres Therapeutics(MCRB)2022-11-03 02:06
Seres Therapeutics, Inc. (NASDAQ:MCRB) Q3 2022 Earnings Conference Call November 2, 2022 8:30 AM ET Company Participants Carlo Tanzi - Head of Investor Relations Eric Shaff - President & Chief Executive Officer Lisa von Moltke - Chief Medical Officer Matthew Henn - Chief Scientific Officer David Arkowitz - Chief Financial Officer Teresa Young - Chief Commercial & Strategy Officer Conference Call Participants Peyton Bohnsack - Cowen Ted Tenthoff - Piper Sandler Mark Breidenbach - Oppenheimer John Newman - Ca ...